Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
XH-001 by NeoCura Bio-Medical Technology for Solid Tumor: Likelihood of Approval
XH-001 is under clinical development by NeoCura Bio-Medical Technology and currently in Phase II for Solid Tumor. According to GlobalData,...